The “Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and Forecast (2021-2031)” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Vaccine…
Kardium Secures $250M (CA$340M) to Launch Advanced Atrial Fibrillation Therapy The developer of the Globe® Pulsed Field System – an innovative treatment for atrial fibrillation (AF) – has raised US$250 million in a…
A leading cardiovascular digital health company announced the launch of the CardioCare Research Suite, a significant expansion of its flagship platform designed to streamline and enhance patient identification for clinical…
A specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success…
Alto Neuroscience, a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today highlighted The Lancet Psychiatry publication of data from the PAX-D study evaluating pramipexole in…
AngelEye Health, a leader in neonatal and pediatric family engagement services, today announced three leadership appointments that reflect the company’s continued momentum and expanding focus on scalable, compassionate care innovation.…
Kopin to Present Advanced Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025 Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for…
NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world’s first surgical correction of a complex ventricular…
Alcon (SIX/NYSE: ALC), the global eye care leader dedicated to helping people see with clarity, today announced the approval of the Clareon MD PanOptix MD Pro intraocular lens (IOL) for cataract patients in…
Invivoscribe is pleased to announce that the NPM1 MRD Assay developed by its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine ® (LabPMM), has been approved by the State of New York. This approval…
The HRT Club, a leading pioneer of direct-to-consumer hormone replacement therapies, today announced a strategic partnership with Posterity Health, the leader in expert-led, comprehensive men’s health. Together, the two companies are…
MediStreams and Availity® Celebrate 10 Years of Innovation, Automating $61 Billion in Healthcare Revenue Cycle Payments MediStreams, a leader in revenue cycle remittance automation, and Availity, the nation’s largest dual-sided…